OF
CGEM icon

Optimize Financial’s Cullinan Oncology CGEM Stock Holding History

Optimize Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$511K Sell
28,061
-97
-0.3% -$1.44K 0.18% 135
2026
Q1 		$400K Buy
+28,158
New +$362K 0.2% 195
2025
Q1 		– Sell
-11,755
Closed -$143K – 236
2024
Q4 		$143K Buy
+11,755
New +$169K 0.11% 229

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Optimize Financial's CGEM Position: Q2 2026 in Review

Optimize Financial reduced its Cullinan Oncology (CGEM) stake by 0.34% in Q2 2026, selling an estimated $1.44K and leaving 28,061 shares worth $511K. The position accounts for 0.18% of the portfolio, ranked #135.

Optimize Financial first reported a position in CGEM in Q4 2024 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Optimize Financial held 28,061 shares of Cullinan Oncology worth $511K as of Q2 2026.
  • Optimize Financial sold 97 Cullinan Oncology shares in Q2 2026, an estimated $1.44K.
  • Cullinan Oncology made up 0.18% of Optimize Financial's portfolio in Q2 2026, its #135 holding.
  • Optimize Financial first reported a position in Cullinan Oncology in Q4 2024 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.